An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)
PHASE3CompletedINTERVENTIONAL
Enrollment
1,873
Participants
Timeline
Start Date
January 31, 2001
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Conditions
Aortic Stenosis
Interventions
DRUG
ezetimibe (+) simvastatin
Duration of Treatment: 4 years
DRUG
Comparator: Placebo
matching Placebo
All Listed Sponsors
lead
Organon and Co
INDUSTRY
NCT00092677 - An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED) | Biotech Hunter | Biotech Hunter